GSK3882347

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

Uncomplicated Urinary Tract InfectionsUrinary Tract Infections

Phase 1

Safety, Tolerability and Pharmacokinetic Investigation of GSK3882347 in Healthy Participants.

CompletedNCT04488770

GlaxoSmithKlineUrinary Tract Infections

Start: 2020-08-24End: 2021-05-14Updated: 2023-02-17

Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections

CompletedNCT05138822

GlaxoSmithKlineUncomplicated Urinary Tract Infections, Urinary Tract Infections

Start: 2022-05-18End: 2024-12-03Updated: 2026-03-13

Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 Years

CompletedNCT05760261

GlaxoSmithKlineUrinary Tract Infections

Start: 2023-04-11End: 2024-08-20Updated: 2025-01-16